The new biology, powerful new techniques for brain imaging and standardized nomenclature and case de®nitions 1 should prime the ®eld of rheumatology to rewrite the literature on neuropsychiatric lupus (NP lupus) . Phenomenologic studies, such as presented in the featured article by Sanna and colleagues, 2 extends our knowledge and raise interesting possibilities about potential mechanisms of pathogenesis.
One major ®nding of this study is that the SPECT scan correlate with disease activity as measured by the SLAM. That SPECT could be used as an indicator of disease activity has major implications for disease management. However, it would have been informative to know if abnormal SPECTs correlate SLAM with overall SLAM scores, or if the correlations were due primarily to the SLAM CNS subscale. Abnormal SPECT scans have been described in patients with clinically inactive lupus and gives substance to the notion that occult CNS involvement can occur in isolation. This might explain the syndrome of cognitive de®cits which, some believe, may be the most common neuropsychiatric manifestation in SLE.
Other novel ®ndings include the strong association between anti-glial ®brillary acidic protein (GFAP) serum antibody with neuropsychiatric symptoms, and the association with anti-PR3 antibody and abnormal SPECT scans. Although an a priori reason for studying anti-PR3 is not given, its association with abnormal functional imaging is intriguing since anti-PR3 has been most strongly associated with necrotizing vasculitis, a ®nding that is rare in autopsy studies of NP lupus.
The investigators performed a number of serological evaluations of the subjects systemically, but most of the testing appears to have been carried out in different laboratories. Ideally, testing should be done in one laboratory and in a single batch to minimize measurement error. The ACR Committee on Neuropsychiatric Lupus Nomenclature 1 wrestled with the role of these and other immunochemical tests and felt that the many immunologic abnormalities described in NP lupus had only weak or inconsistent associations with clinical syndromes. They observed that these inconclusive data might have been due to lack of standardized assays, on the one hand, and the lack of standard case de®nitions on the other, both of which might have been problems in this study.
Finally, the authors are to be commended on their meticulous work but one should be cautious in interpreting the results when so many observations (at least 30 variables by our estimate) are done on a relatively small number of subjects. Multiple comparisons can be appropriate in an exploratory study. If the comparisons were limited there might be a chance that a biological trend or association would be overlooked. Nevertheless, in repeated comparisons, one in 20 could be signi®-cant at the 5% level by chance alone. 3, 4 Therefore, these interesting ®ndings should be considered preliminary and as grist for further research.
